Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
off-target binding
Description:
Off-target binding is the unintended association of a molecule, such as a drug or guide-RNA complex, with a site other than its intended target.
Related topics:
Computational Drug Discovery Methods (15%),
Alzheimer's disease research and treatments (12%),
Monoclonal and Polyclonal Antibodies Research (8%)
OpenAlex ID:
keywords/off-target-binding
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
2013
·
Prashant Mali
, John Aach
, et al.
·
Nature Biotechnology
·
1,803
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
2014
·
Xuebing Wu
, David A Scott
, et al.
·
Nature Biotechnology
·
990
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
2014
·
Cem Kuscu
, Sevki Arslan
, et al.
·
Nature Biotechnology
·
806
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue
2015
·
Marta Marquié
, Marc D. Normandin
, et al.
·
Annals of Neurology
·
638
An autoradiographic evaluation of AV-1451 Tau PET in dementia
2016
·
Val J. Lowe
, Geoffry Curran
, et al.
·
Acta Neuropathologica Communications
·
493
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
2017
·
Liming Liu
·
Protein & Cell
·
417
PDF
Dynamics of CRISPR-Cas9 genome interrogation in living cells
2015
·
Spencer C. Knight
, Liangqi Xie
, et al.
·
Science
·
369
Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening
2006
·
Nicolas Foloppe
, Lisa M. Fisher
, et al.
·
Bioorganic & Medicinal Chemistry
·
366
Considerations and code for partial volume correcting [ 18 F]-AV-1451 tau PET data
2017
·
Suzanne L. Baker
, Anne Maass
, et al.
·
Data in Brief
·
306
PDF
Identification of Direct Protein Targets of Small Molecules
2010
·
Brett Lomenick
, Richard W. Olsen
, et al.
·
ACS Chemical Biology
·
305
PDF
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
2010
·
Stéphanie Pérot
, Olivier Sperandio
, et al.
·
Drug Discovery Today
·
289
Engineering siRNA therapeutics: challenges and strategies
2023
·
Syed Saqib Ali Zaidi
, Faria Fatima
, et al.
·
Journal of Nanobiotechnology
·
286
PDF
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18 F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
2018
·
Tobey J Betthauser
, Karly A Cody
, et al.
·
Journal of Nuclear Medicine
·
272
PDF
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
2017
·
Dimitri E. Grigoriadis
, Evan Smith
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
253
PDF
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
2014
·
Apirat Chaikuad
, Eliana M C Tacconi
, et al.
·
Nature Chemical Biology
·
253
A strategy for risk mitigation of antibodies with fast clearance
2012
·
Isidro Hötzel
, Frank-Peter Theil
, et al.
·
mAbs
·
248
PDF
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
2009
·
Roger Yazbeck
, Gordon S. Howarth
, et al.
·
Trends in Pharmacological Sciences
·
246
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
2014
·
Stuart W. J. Ember
, Jin-Yi Zhu
, et al.
·
ACS Chemical Biology
·
231
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
2015
·
Henriette O'Geen
, Isabelle M. Henry
, et al.
·
Nucleic Acids Research
·
220
PDF
High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding
2017
·
Evan A. Boyle
, Johan O. L. Andreasson
, et al.
·
Proceedings of the National Academy of Sciences
·
206
PDF
A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs
2018
·
Christian Pflueger
, Dennis Tan
, et al.
·
Genome Research
·
197
PDF
Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies
2016
·
Marta Marquié
, Marc D. Normandin
, et al.
·
Annals of Neurology
·
197
The development and validation of tau PET tracers: current status and future directions
2018
·
Nobuyuki Okamura
, Ryuichi Harada
, et al.
·
Clinical and Translational Imaging
·
196
PDF
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
2020
·
André Fischer
, Manuel Sellner
, et al.
·
International Journal of Molecular Sciences
·
193
PDF
Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles
2014
·
Jing Tang
, Tero Aittokallio
·
Current Pharmaceutical Design
·
192
PDF
Show more works
View as search
Works count:
980
Citation count:
25,870
Year
Topic
Type